申请人:Zhang Lixin
公开号:US20130116243A1
公开(公告)日:2013-05-09
The invention relates to a series of compounds with particular activity as inhibitors of the serine-threonine kinase AKT. Also provided are pharmaceutical compositions comprising same as well as methods for treating cancer.
本发明涉及一系列具有特定活性的化合物,作为丝氨酸/苏氨酸激酶AKT的抑制剂。同时,本发明还提供了包含这些化合物的制药组合物,以及治疗癌症的方法。